Looks like the MAD/MTD will be at 750 mg/m2. I'm l
Post# of 72444
"On Monday, November 9, 2015, the sixth qualifying patient in the present cohort received their third Kevetrin treatment at 750 mg/m2. To wit, enrollment in the Kevetrin Phase 1 clinical trial is now closed to new subjects. The decision to formally conclude the trial will now be reviewed by the Company and Principal Investigator."


Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
